| Barchart Demo Center |
$1.3800
+0.0600 (+4.55%)
as of May 31, 2024
as of May 31, 2024
| Profile | |
|---|---|
| Ticker Symbol | CATX |
| Exchange | AMEX |
| Contact Information |
2401 ELLIOTT AVENUE SUITE 320 SEATTLE, WA USA P: 206-676-0900 |
| CEO/President | Johan Thijs Spoor |
| Earnings at a Glance | ||||
|---|---|---|---|---|
| Earnings | 03/31/24 -0.02 |
12/31/23 -0.09 |
09/30/23 -0.04 |
06/30/23 -0.04 |
| Price Earnings Ratio | N/A | |||
| EPS Growth | 25.00 | |||
| Most Recent Earnings ($) | -0.0200 | |||
| Annual EPS ($) | N/A | |||
| Business Summary | |
|---|---|
| Perspective Therapeutics Inc. is a medical technology and radiopharmaceutical company which provide advanced treatment applications for cancers. The Company is the sole producer of Cesium-131 brachytherapy seeds. Perspective Therapeutics Inc. formerly known as Isoray Inc. is based in RICHLAND Wash. | |
| Industry/Sector | SIC-3841 Surgical & Medical Instruments & Apparatus Medical - Drugs |